Collaboration Programs
Beijing Capital University
In construction
Capital Medical University (CCMU) was founded in 1960. It ranks among the top academic medical institutions in China, and is considered as one of the key municipal universities in Beijing. The founding President, Professor Wu Jieping, was a world-renowned urologist, member of both the Chinese Academy of Sciences and the Chinese Academy of Engineering. The current President is Professor Lu Zhaofeng.
CCMU consists of 10 Schools, 14 affiliated hospitals and 1 teaching institution. The university and the affiliated hospitals have a staff of about 20,000. Among the staff, there are 6 members of the Chinese Academy of Sciences or the Chinese Academy of Engineering, over 1,000 professors, and over 2,000 associate professors. The university has over 9,000 enrolled students. CMU provides a wide range of educational programs for Doctorates, Masters, Bachelors and certificates.
The faculty physicians at CCMU train annually several thousands of clinical residents and fellows. Also, the faculty members also provide continuous medical education to physicians and other health professionals through seminars, teaching rounds, and tutorials on and off campus. Over the years, the university has graduated a large number of academic leaders and general practitioners for Beijing and the whole country.
CCMU is a well known academic institution for its strong competence in the scientific research. It hosts many national and municipal key disciplines, laboratories and some exchange stations for post-doctoral research. High-caliber national and municipal research and training centers and institutes are founded here, covering a wide range of fields including General Practitioner Training, Clinical Medicine, Basic Medicine, Neurosciences, Ophthalmology, Geriatrics, Urology, Cardiology, Pain Medicine, Toxicology, Biomedical Engineering, Traditional Chinese Medicine, Reproduction, Health Policy and so on. We have achieved national and international recognitions in many areas such as Neurobiology, Cytobiology, Immunology, Medical Iconography, Neurology, Neurosurgery, Cardiology, Cardio-vascular Surgery, Kidney Transplantation, Respiratory Disease, Digestive Medicine, Oral-Maxillofacial Surgery, Ophthalmology, Otolaryngology and Pediatric Hematology, among others.
CCMU provides excellent international exchange programs. It has partnerships and agreements with many universities and institutions with more than 20 countries and regions, supporting activities such as faculty and student exchange programs, joint education and joint research projects.
CCMU is proud to be at the forefront in the medical education, biomedical research and patient care. It is committed to bring the latest knowledge in basic and clinical sciences for peoples’ care. I do hope CMU will develop quickly and well in the century.
https://ccmu.cucas.cn/introduction/
Beijing Obstetrics & Gynecology Hospital
Capital Medical University
Description of the hospital should be given here
Key person of the exchange program
Professor Dr. Xiangyan Ruan, MD
Director of the Department of Endocrinology for Gynecology,
Director of the Menopause Clinic,
and Director for the Fertility Protection Centre
Beijing Obstetrics & Gynecology Hospital
Capital Medical University
251 Yao Jiao Yuan Road
Chao yang District,
Beijing, 100026, P.R. China
托马斯·拉贝教授等德国团队与首都医科大学附属北京妇产医院阮祥燕教授团队合作项目成果
托马斯·拉贝教授与北京妇产医院的合作始于2011年，13年来，他为中国生殖妇科内分泌领域的发展做出了重要贡献。托马斯·拉贝教授等德国团队与首都医科大学附属北京妇产医院阮祥燕教授团队合作创建了20余项国际领先、国内先进项目。
1. 托马斯·拉贝教授2013年被聘为首都医科大学客座教授+
2013 年首都医科大学校长吕兆丰（右1）与北京妇产医院院长严松彪（左1）为托马斯·拉贝颁发客座教授证书
2. 阮祥燕团队创建“北京妇科内分泌疑难病研究会诊中心”
托马斯·拉贝教授在首都医科大学附属北京妇产医院阮祥燕团队的妇科内分泌科进行疑难病教学会诊，院领导到门诊看望托马斯·拉贝教授
3. 阮祥燕团队创建中国首个门诊微型宫腔镜中心
阮祥燕团队引进了微型宫腔镜技术，建立中国首个门诊微型宫腔镜培训中心，为异常子宫出血、不孕不育等提供了无创、简便、经济的检查手段
4. 阮祥燕团队创建了“中国首个国际跨学科子宫内膜异位症中心”
2017年9月在阿尔弗雷德·缪克教授、托马斯·拉贝教授的引荐帮助下，德方子宫内膜异位症专家到北京妇产医院实地考察评估，决定成立“中国首个国际跨学科子宫内膜异位症中心”，阮祥燕教授任中心主任。
5. 阮祥燕教授同托马斯·拉贝教授、缪克教授等国际专家合著多部学术专著与译著
阮祥燕教授与托马斯·拉贝教授、阿尔弗雷德·缪克教授合著出版的部分研究成果：《生殖内分泌学热点聚焦》、《妇科内分泌热点聚焦》、《生殖内分泌学临床实践》、《更年期与妇科内分泌疑难病例评析》4部专著。阮祥燕还带领团队翻译了《拉贝与中国》一书
6. 阮祥燕带领团队十年攻坚克难，创建中国个人卵巢组织冻存库
在阿尔弗雷德·缪克教授、托马斯·拉贝教授等国际团队的帮助下，阮祥燕教授带领团队经十余年艰苦奋斗，将卵巢组织冻存移植技术创新性的在中国实现了从临床研究到临床应用的科技转化。三次填补中国生育力保护保存史的空白。
2012年4月阮祥燕团队在首都医科大学附属北京妇产医院创建了中国首个卵巢组织冻存库，第一次填补中国生育力保护保存史的空白；
2016年阮祥燕团队在首都医科大学附属北京妇产医院完成中国首例卵巢组织冻存移植，第二次填补中国生育力保护保存史的空白；
2018年内分泌科阮祥燕牵头制定中国首个《卵巢组织冻存移植指南》[1]，发表在国际妇科内分泌学会官方期刊《Gynecological Endocrinology》；
2020年12月阮祥燕团队实现中国冻存卵巢组织移植后首例自然妊娠；
2021年8月，阮祥燕团队成功实现中国首例冻存卵巢组织移植后首例健康婴儿诞生，第三次填补中国生育力保护保存史的空白；
2023年牵头制定了国际首部卵巢组织冻存移植技术规范团体标准[2]。
2024年1月，阮祥燕团队又创立了中国冻存卵巢组织移植后第二例自然妊娠的新纪录！
目前阮祥燕团队已冻存儿童及年轻患者的卵巢组织超过600例，年龄最小的只有7个月，未出现任何术中术后并发症。移植26例，未出现与移植相关原发病的复发，移植成功率100%，达国际领先水平！卵巢组织冻存相关的所有收费项目已于2021年全部获批，实现了临床应用的重大科技转化；并初步建立了全国生育力保护网络，实现卵巢组织冻存技术优质医疗资源的下沉扩容、推广应用。
阮祥燕教授与中国冻存卵巢组织移植后首例宝宝
2023年中国冻存卵巢组织移植后首例宝宝两周岁
7. 2018年托马斯·拉贝教授获得中国政府友谊奖
2018年9月李克强总理会见托马斯·拉贝教授
2018年9月刘鹤副总理会见托马斯·拉贝教授
北京妇产医院院领导及阮祥燕团队庆祝托马斯·拉贝教授获得中国政府友谊奖
参考文献：
[1]. Ruan X. Chinese Society of Gynecological Endocrinology affiliated to the International Society of Gynecological Endocrinology Guideline for Ovarian Tissue Cryopreservation and Transplantation[J]. Gynecol Endocrinol, 2018,34(12):1005-1010.
[2]. 首都医科大学附属北京妇产医院, 中国人体健康科技促进会生育力保护与保存专业委员会, 阮祥燕. 卵巢组织冻存移植技术规范团体标准[J]. 中国全科医学, 2023,26(23):2836-2841.